LIFECORE BIOMEDICAL, INC. Revenue from Related Parties
LIFECORE BIOMEDICAL, INC. (LFCR) reported Revenue from Related Parties of $72.00 thousand for the 3-month period ending 2017-02-26, per its 10-Q filed 2017-04-07.
Discontinued › Income Statement › Other Income
us-gaap:RevenueFromRelatedParties · last filed 2017-04-07
- LIFECORE BIOMEDICAL, INC. revenue from related parties for the quarter ending 2017-02-26 was $72.00K, a 33.94% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. revenue from related parties for the quarter ending 2016-11-27 was $75.00K, a 46.43% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. revenue from related parties for the quarter ending 2016-08-28 was $118.00K, a 6.35% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. revenue from related parties for the quarter ending 2016-02-28 was $109.00K.
- LIFECORE BIOMEDICAL, INC. revenue from related parties for fiscal 2013 was $2.13M, a 31.99% decline from fiscal 2012.
- LIFECORE BIOMEDICAL, INC. revenue from related parties for fiscal 2012 was $3.14M, a 7.46% decline from fiscal 2011.
- LIFECORE BIOMEDICAL, INC. revenue from related parties for fiscal 2011 was $3.39M, a 8.33% decline from fiscal 2010.
- LIFECORE BIOMEDICAL, INC. revenue from related parties for fiscal 2010 was $3.70M.
| Period end | Revenue from Related Parties 3 month | Revenue from Related Parties 6 month | Revenue from Related Parties 9 month | Revenue from Related Parties 12 month |
|---|---|---|---|---|
| 2017-02-26 | $72.00K 10-Q · filed 2017-04-07 | $147.00K derived: sum of 2 quarters · filed 2017-04-07 | $265.00K 10-Q · filed 2017-04-07 | |
| 2016-11-27 | $75.00K 10-Q · filed 2017-01-05 | $193.00K 10-Q · filed 2017-01-05 | ||
| 2016-08-28 | $118.00K 10-Q · filed 2016-09-29 | |||
| 2016-02-28 | $109.00K 10-Q · filed 2017-04-07 | $249.00K derived: sum of 2 quarters · filed 2017-04-07 | $376.00K 10-Q · filed 2017-04-07 | |
| 2015-11-29 | $140.00K 10-Q · filed 2017-01-05 | $266.00K 10-Q · filed 2017-01-05 | ||
| 2015-08-30 | $126.00K 10-Q · filed 2016-09-29 | |||
| 2014-02-23 | $350.00K 10-Q · filed 2014-03-28 | $825.00K derived: sum of 2 quarters · filed 2014-03-28 | $1.38M 10-Q · filed 2014-03-28 | $1.89M derived: sum of 4 quarters · filed 2014-03-28 |
| 2013-11-24 | $475.00K 10-Q · filed 2014-01-03 | $1.02M 10-Q · filed 2014-01-03 | $1.54M derived: sum of 3 quarters · filed 2014-01-03 | $1.82M derived: sum of 4 quarters · filed 2014-03-28 |
| 2013-08-25 | $550.00K 10-Q · filed 2013-09-26 | $1.07M derived: sum of 2 quarters · filed 2013-09-26 | $1.35M derived: sum of 3 quarters · filed 2014-03-28 | $1.91M derived: sum of 4 quarters · filed 2014-03-28 |
| 2013-05-26 | $516.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $799.00K derived: sum of 2 quarters · filed 2014-03-28 | $1.36M derived: sum of 3 quarters · filed 2014-03-28 | $2.13M 10-K · filed 2013-08-07 |
| 2013-02-24 | $283.00K 10-Q · filed 2014-03-28 | $846.00K derived: sum of 2 quarters · filed 2014-03-28 | $1.62M 10-Q · filed 2014-03-28 | $2.42M derived: sum of 4 quarters · filed 2014-03-28 |
| 2012-11-25 | $563.00K 10-Q · filed 2014-01-03 | $1.33M 10-Q · filed 2014-01-03 | $2.14M derived: sum of 3 quarters · filed 2014-01-03 | $2.69M derived: sum of 4 quarters · filed 2014-01-03 |
| 2012-08-26 | $771.00K 10-Q · filed 2013-09-26 | $1.58M derived: sum of 2 quarters · filed 2013-09-26 | $2.12M derived: sum of 3 quarters · filed 2013-09-26 | $2.93M derived: sum of 4 quarters · filed 2013-09-26 |
| 2012-05-27 | $808.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $1.35M derived: sum of 2 quarters · filed 2013-08-07 | $2.16M derived: sum of 3 quarters · filed 2013-08-07 | $3.14M 10-K · filed 2013-08-07 |
| 2012-02-26 | $545.00K 10-Q · filed 2013-04-04 | $1.35M derived: sum of 2 quarters · filed 2013-04-04 | $2.33M 10-Q · filed 2013-04-04 | $3.12M derived: sum of 4 quarters · filed 2013-08-07 |
| 2011-11-27 | $805.00K 10-Q · filed 2013-01-04 | $1.78M 10-Q · filed 2013-01-04 | $2.58M derived: sum of 3 quarters · filed 2013-08-07 | $3.13M derived: sum of 4 quarters · filed 2013-08-07 |
| 2011-08-28 | $980.00K 10-Q/A · filed 2013-01-02 | $1.77M derived: sum of 2 quarters · filed 2013-08-07 | $2.32M derived: sum of 3 quarters · filed 2013-08-07 | $3.31M derived: sum of 4 quarters · filed 2013-08-07 |
| 2011-05-29 | $791.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $1.34M derived: sum of 2 quarters · filed 2013-08-07 | $2.33M derived: sum of 3 quarters · filed 2013-08-07 | $3.39M 10-K · filed 2013-08-07 |
| 2011-02-27 | $549.00K 10-Q · filed 2012-03-28 | $1.53M derived: sum of 2 quarters · filed 2012-03-28 | $2.60M 10-Q · filed 2012-03-28 | |
| 2010-11-28 | $986.00K 10-Q · filed 2012-01-05 | $2.05M 10-Q · filed 2012-01-05 | ||
| 2010-08-29 | $1.06M 10-Q · filed 2011-10-05 | |||
| 2010-05-30 | $3.70M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |